These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38636893)

  • 1. CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma.
    Zhuo R; Zhang Z; Chen Y; Li G; Du S; Guo X; Yang R; Tao Y; Li X; Fang F; Xie Y; Wu D; Yang Y; Yang C; Yin H; Qian G; Wang H; Yu J; Jia S; Zhu F; Feng C; Wang J; Xu Y; Li Z; Shi L; Wang X; Pan J; Wang J
    Cancer Lett; 2024 Jun; 591():216882. PubMed ID: 38636893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling.
    Wang JB; Wang ZW; Li Y; Huang CQ; Zheng CH; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Lin Y; Huang CM
    Cancer Lett; 2017 Jan; 385():188-197. PubMed ID: 27793695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ΔNp63α is a super enhancer-enriched master factor controlling the basal-to-luminal differentiation transcriptional program and gene regulatory networks in nasopharyngeal carcinoma.
    Cai J; Chen S; Yi M; Tan Y; Peng Q; Ban Y; Yang J; Li X; Zeng Z; Xiong W; McCarthy JB; Li G; Li X; Xiang B
    Carcinogenesis; 2020 Sep; 41(9):1282-1293. PubMed ID: 31826234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK5RAP3 Participates in Autophagy Regulation and Is Downregulated in Renal Cancer.
    Li J; Hu X; Su M; Shen H; Qiu W; Tian Y
    Dis Markers; 2019; 2019():6171782. PubMed ID: 31061682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3.
    Egusquiaguirre SP; Liu S; Tošić I; Jiang K; Walker SR; Nicolais M; Saw TY; Xiang M; Bartel K; Nelson EA; Frank DA
    Neoplasia; 2020 Jan; 22(1):47-59. PubMed ID: 31765941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression.
    Jiang Y; Jiang YY; Xie JJ; Mayakonda A; Hazawa M; Chen L; Xiao JF; Li CQ; Huang ML; Ding LW; Sun QY; Xu L; Kanojia D; Jeitany M; Deng JW; Liao LD; Soukiasian HJ; Berman BP; Hao JJ; Xu LY; Li EM; Wang MR; Bi XG; Lin DC; Koeffler HP
    Nat Commun; 2018 Sep; 9(1):3619. PubMed ID: 30190462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-enhancer-driven IRF2BP2 enhances ALK activity and promotes neuroblastoma cell proliferation.
    Chen YL; Zhuo R; Sun LC; Tao YF; Li G; Zhu F; Xu YY; Wang JW; Li ZH; Yu JJ; Yin HL; Wu D; Li XL; Fang F; Xie Y; Hu YZ; Wang HR; Yang C; Shi L; Wang XD; Zhang ZM; Pan J
    Neuro Oncol; 2024 Jun; ():. PubMed ID: 38864832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK5RAP3, an essential regulator of checkpoint, interacts with RPL26 and maintains the stability of cell growth.
    Yan H; Xu JJ; Ali I; Zhang W; Jiang M; Li G; Teng Y; Zhu G; Cai Y
    Cell Prolif; 2022 May; 55(5):e13240. PubMed ID: 35509151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK5RAP3 is a novel repressor of p14ARF in hepatocellular carcinoma cells.
    Mak GW; Lai WL; Zhou Y; Li M; Ng IO; Ching YP
    PLoS One; 2012; 7(7):e42210. PubMed ID: 22860085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
    Mak GW; Chan MM; Leong VY; Lee JM; Yau TO; Ng IO; Ching YP
    Cancer Res; 2011 Apr; 71(8):2949-58. PubMed ID: 21385901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ISL1 promoted tumorigenesis and EMT via Aurora kinase A-induced activation of PI3K/AKT signaling pathway in neuroblastoma.
    Li M; Sun C; Bu X; Que Y; Zhang L; Zhang Y; Zhang L; Lu S; Huang J; Zhu J; Wang J; Sun F; Zhang Y
    Cell Death Dis; 2021 Jun; 12(6):620. PubMed ID: 34131100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.
    Li D; Mei H; Qi M; Yang D; Zhao X; Xiang X; Pu J; Huang K; Zheng L; Tong Q
    Oncotarget; 2013 Nov; 4(11):2021-44. PubMed ID: 24269992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK5RAP3 Deficiency Restrains Liver Regeneration after Partial Hepatectomy Triggering Endoplasmic Reticulum Stress.
    Yang S; Yang R; Wang H; Huang Y; Jia Y
    Am J Pathol; 2020 Dec; 190(12):2403-2416. PubMed ID: 32926856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation.
    Banerjee D; Bagchi S; Liu Z; Chou HC; Xu M; Sun M; Aloisi S; Vaksman Z; Diskin SJ; Zimmerman M; Khan J; Gryder B; Thiele CJ
    Nat Commun; 2024 Apr; 15(1):3432. PubMed ID: 38653778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MSX1 homeobox transcription factor is a downstream target of PHOX2B and activates the Delta-Notch pathway in neuroblastoma.
    Revet I; Huizenga G; Chan A; Koster J; Volckmann R; van Sluis P; Øra I; Versteeg R; Geerts D
    Exp Cell Res; 2008 Feb; 314(4):707-19. PubMed ID: 18201699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma.
    Deng R; Huang JH; Wang Y; Zhou LH; Wang ZF; Hu BX; Chen YH; Yang D; Mai J; Li ZL; Zhang HL; Huang Y; Peng XD; Feng GK; Zhu XF; Tang J
    Mol Cancer; 2020 Aug; 19(1):122. PubMed ID: 32771023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CASZ1 inhibits cell cycle progression in neuroblastoma by restoring pRb activity.
    Liu Z; Rader J; He S; Phung T; Thiele CJ
    Cell Cycle; 2013 Jul; 12(14):2210-8. PubMed ID: 23892435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.
    Wang C; Liu Z; Woo CW; Li Z; Wang L; Wei JS; Marquez VE; Bates SE; Jin Q; Khan J; Ge K; Thiele CJ
    Cancer Res; 2012 Jan; 72(1):315-24. PubMed ID: 22068036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene.
    Ambrosio S; Amente S; Saccà CD; Capasso M; Calogero RA; Lania L; Majello B
    Oncotarget; 2017 Jan; 8(3):3854-3869. PubMed ID: 27894074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.